WHITE PAPER

Adapt or Fail:
The Urgency of Pandemic Preparedness for Sterile Injectable Manufacturing

Download our white paper to read the full article:

Throughout the pandemic, Jubilant HollisterStier’s (JHS) flexibility allowed us to manage numerous time-sensitive projects. One of our key goals as part of a pandemic response is to ready a product for Emergency Use Authorization (EUA) approval, which we were able to fulfill during COVID. Our experienced team anticipated and addressed potential timeline obstacles while focusing on our commitment to compliance and quality standards. Based on what we’ve learned over the past several years, we maintain a viable balance between daily operational effectiveness and pandemic readiness as we produce sterile injectable and fill-finish solutions for patients around the world.